Impact of Adult Congenital Heart Disease Specialist Visits on Emergent Admissions: Evidence for Guidelines
- PMID: 40730048
- PMCID: PMC12319251
- DOI: 10.1016/j.jacadv.2025.102021
Impact of Adult Congenital Heart Disease Specialist Visits on Emergent Admissions: Evidence for Guidelines
Abstract
Background: Although routine outpatient visits with adult congenital heart defect (ACHD) specialists have been recommended, the evidence to support this remains sparse.
Objectives: The purpose of this study was to evaluate the association between outpatient ACHD visits and emergent admissions.
Methods: This observational study used standardized electronic health record data from 13 health centers from January 1, 2015 through December 31, 2019. Mixed logistic regression analyses examined the effects of number of outpatient ACHD specialist visits (1-2 considered routine) during a 6-month period on an emergent admission in the subsequent 6-month period, after adjusting for cohort characteristics, CHD severity, and center. Analysis was stratified by ACHD anatomic types and medical conditions associated with or without physiological CHD class.
Results: The 16,142 patients (median age 32 years, 44.9% women, 83.2% White) contributed to 118,079 person-periods, an average of 7.3 periods per person. Between 1.3% and 2.7% of patients had one emergent admission per 6-month period. Patients with zero, 3, 4, or more than 4 prior outpatient visits had 1.34, 1.67, 2.08-, and 2.48 times higher odds of emergent admission, respectively, than those with a prior routine visit (P < 0.05 using the Wald test). The stratified adjusted analysis demonstrated similar J-shaped (nonlinear) relationships by presence of medical conditions but not by anatomic type.
Conclusions: Having routine outpatient ACHD specialist visits over a 6-month period reduces the likelihood of an emergent admission in the subsequent period, findings driven by presence of medical conditions and not anatomic severity. These findings provide supporting evidence for the ACHD guidelines and implementation science research.
Keywords: adult congenital heart disease; emergent admissions; outcomes; outpatient visits.
Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Funding support and author disclosures The study reported in this work was powered by PCORnet, which has been developed with funding from the Patient-Centered Outcomes Research Institute (PCORI). The study was funded through the PCORI Award (RD-2020C2-20347). Dr Agarwal was supported by the grant K23 HL151866 from National Heart, Lung, and Blood Institute (NHLBI) during the conduct of this study. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures






Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Understanding patient pathways to Mother and Baby Units: a longitudinal retrospective service evaluation in the UK.Health Soc Care Deliv Res. 2025 Jul 16:1-17. doi: 10.3310/GDVS2427. Online ahead of print. Health Soc Care Deliv Res. 2025. PMID: 40682791
-
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23. Clin Orthop Relat Res. 2024. PMID: 39051924
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
References
-
- Khairy P., Ionescu-Ittu R., Mackie A.S., Abrahamowicz M., Pilote L., Marelli A.J. Changing mortality in congenital heart disease. J Am Coll Cardiol. 2010;56(14):1149–1157. - PubMed
-
- Stout K.K., Daniels C.J., Aboulhosn J.A., et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation. 2018;139(14):e637–e697. doi: 10.1161/CIR.0000000000000602. - DOI - PubMed
LinkOut - more resources
Full Text Sources